import{c as M,r as d,j as e,h as k,R as L,a as F,D as G,T as H,C as A,X as $,a3 as q,a4 as V,a5 as P,U as Y,E,S as W,Q as _}from"./index-4Ly-s4cr.js";import{A as K}from"./AutoComplete-DKJQY6mP.js";import{C as h}from"./Card-DLOVFYwQ.js";import{A as U}from"./arrow-left-DpJZujVo.js";import{T as I}from"./tag-COrFYHX4.js";import{S as Q}from"./settings-BG7XI4yB.js";import{C as X}from"./circle-play-DgjKDzSY.js";import{M as J}from"./maximize-2-8Nyq9FbK.js";import{U as Z}from"./user-BBF1fMpu.js";import{A as O}from"./Alert-D2KfDB-X.js";import{M as R}from"./message-circle-BnO2y0e8.js";import{M as D}from"./mail-C7SWvgQs.js";import"./LoadingSpinner-BK8GoEPg.js";import"./check-pB4liXIF.js";import"./circle-x-DA35Ia3u.js";import"./circle-check-big-DzqNVPmE.js";/**
 * @license lucide-react v0.544.0 - ISC
 *
 * This source code is licensed under the ISC license.
 * See the LICENSE file in the root directory of this source tree.
 */const ee=[["path",{d:"M4 19.5v-15A2.5 2.5 0 0 1 6.5 2H19a1 1 0 0 1 1 1v18a1 1 0 0 1-1 1H6.5a1 1 0 0 1 0-5H20",key:"k3hazp"}]],j=M("book",ee);/**
 * @license lucide-react v0.544.0 - ISC
 *
 * This source code is licensed under the ISC license.
 * See the LICENSE file in the root directory of this source tree.
 */const te=[["path",{d:"M12 8V4H8",key:"hb8ula"}],["rect",{width:"16",height:"12",x:"4",y:"8",rx:"2",key:"enze0r"}],["path",{d:"M2 14h2",key:"vft8re"}],["path",{d:"M20 14h2",key:"4cs60a"}],["path",{d:"M15 13v2",key:"1xurst"}],["path",{d:"M9 13v2",key:"rq6x2g"}]],T=M("bot",te);/**
 * @license lucide-react v0.544.0 - ISC
 *
 * This source code is licensed under the ISC license.
 * See the LICENSE file in the root directory of this source tree.
 */const ie=[["path",{d:"m14 10 7-7",key:"oa77jy"}],["path",{d:"M20 10h-6V4",key:"mjg0md"}],["path",{d:"m3 21 7-7",key:"tjx5ai"}],["path",{d:"M4 14h6v6",key:"rmj7iw"}]],se=M("minimize-2",ie),C=[{id:"getting-started",name:"Getting Started",description:"Learn the basics of OncoSafeRx",icon:"PlayCircle",articles:[{id:"introduction",title:"Introduction to OncoSafeRx",category:"getting-started",tags:["overview","basics","introduction"],difficulty:"beginner",estimatedReadTime:5,lastUpdated:"2025-01-15",content:`
# Introduction to OncoSafeRx

OncoSafeRx is a comprehensive oncology drug interaction and safety platform designed to help healthcare professionals make informed decisions about cancer treatments.

## What is OncoSafeRx?

OncoSafeRx provides:
- **Drug Interaction Checking**: Identify potential interactions between medications
- **Pharmacogenomic Analysis**: Understand how genetics affect drug responses
- **Clinical Decision Support**: Evidence-based recommendations for oncology care
- **Safety Monitoring**: Real-time alerts for drug safety concerns

## Key Features

### üîç Drug Search
Search our comprehensive database of oncology medications, including:
- FDA-approved cancer drugs
- Supportive care medications
- Generic and brand name drugs
- Investigational agents

### ‚ö†Ô∏è Interaction Checker
Check for interactions between multiple medications:
- Drug-drug interactions
- Severity ratings
- Clinical recommendations
- Monitoring requirements

### üß¨ Genomic Analysis
Pharmacogenomic insights including:
- CPIC guidelines
- FDA pharmacogenomic recommendations
- Dosing adjustments based on genetic variants

### üìä Clinical Intelligence
Access to:
- Clinical trial data
- Real-world evidence
- Treatment protocols
- Safety profiles

## Getting Help

- Use the AI chat assistant for instant help
- Browse the knowledge base for detailed guides
- Contact support for technical issues

Start by exploring the Drug Search feature to familiarize yourself with the interface.
        `},{id:"navigation",title:"Navigating the Interface",category:"getting-started",tags:["navigation","interface","basics"],difficulty:"beginner",estimatedReadTime:3,lastUpdated:"2025-01-15",content:`
# Navigating the OncoSafeRx Interface

## Main Navigation

The OncoSafeRx interface consists of several key sections:

### üè† Dashboard
- Overview of recent activity
- Quick access to common tasks
- System status and alerts

### üîç Drug Search
- Search for medications by name, RXCUI, or active ingredient
- View detailed drug information
- Access pharmacokinetic data

### ‚ö†Ô∏è Interaction Checker
- Add multiple medications
- Check for potential interactions
- View severity ratings and recommendations

### üß¨ Genomics
- Enter patient genetic information
- Get pharmacogenomic recommendations
- View CPIC guidelines

### üìö Knowledge Base
- Access user manual and guides
- Search for specific topics
- Browse by category

## Search Tips

### Drug Search
- Type at least 2 characters to see suggestions
- Use generic or brand names
- Search is case-insensitive
- Recent searches are saved for quick access

### Interaction Checker
- Add drugs one at a time
- Minimum 2 drugs required for checking
- Results show severity and clinical recommendations

## Keyboard Shortcuts

- **Ctrl+/** or **Cmd+/**: Open search
- **Ctrl+H** or **Cmd+H**: Open help
- **Escape**: Close modals and dropdowns
        `},{id:"first-search",title:"Your First Drug Search",category:"getting-started",tags:["search","tutorial","drugs"],difficulty:"beginner",estimatedReadTime:4,lastUpdated:"2025-01-15",content:`
# Your First Drug Search

Let's walk through searching for a medication in OncoSafeRx.

## Step 1: Access Drug Search

1. Click on **Drug Search** in the main navigation
2. You'll see the search interface with autocomplete

## Step 2: Enter Search Terms

1. Start typing a medication name (e.g., "pembrolizumab")
2. As you type, you'll see suggestions appear
3. Suggestions include:
   - Generic names
   - Brand names
   - Recent searches (if any)

## Step 3: Select a Medication

1. Click on a suggestion or press Enter
2. You'll see detailed drug information including:
   - Basic drug details (RXCUI, name, type)
   - Clinical information
   - Available actions

## Step 4: Explore Drug Details

From the drug details page, you can:
- **View Interactions**: Check how this drug interacts with others
- **Genomic Analysis**: See pharmacogenomic considerations
- **Clinical Trials**: Find relevant studies

## Example: Searching for Pembrolizumab

1. Type "pembrolizumab" in the search box
2. Select "pembrolizumab 25 MG/ML Injectable Solution"
3. Review the drug information
4. Click "Check Interactions" to see potential drug interactions

## Search Tips

- **Use partial names**: "pembro" will find "pembrolizumab"
- **Case doesn't matter**: "ASPIRIN" = "aspirin"
- **Brand names work**: "Keytruda" will find pembrolizumab
- **Recent searches**: Your last 5 searches are saved for quick access

## Next Steps

Once you're comfortable with drug search:
1. Try the Interaction Checker with multiple drugs
2. Explore genomic analysis features
3. Review clinical decision support tools
        `}]},{id:"drug-interactions",name:"Drug Interactions",description:"Understanding and checking drug interactions",icon:"AlertTriangle",articles:[{id:"interaction-basics",title:"Understanding Drug Interactions",category:"drug-interactions",tags:["interactions","safety","clinical"],difficulty:"intermediate",estimatedReadTime:8,lastUpdated:"2025-01-15",content:`
# Understanding Drug Interactions

Drug interactions can significantly impact patient safety and treatment efficacy in oncology care.

## Types of Drug Interactions

### Drug-Drug Interactions
- **Pharmacokinetic**: Affecting absorption, distribution, metabolism, or excretion
- **Pharmacodynamic**: Affecting drug action at receptor or system level
- **Pharmaceutical**: Physical or chemical incompatibilities

### Drug-Disease Interactions
- Contraindications due to patient conditions
- Dose adjustments needed for organ dysfunction
- Monitoring requirements for specific diseases

### Drug-Food Interactions
- Absorption changes with food
- Specific dietary restrictions
- Timing considerations

## Severity Classifications

### üî¥ Major (Severe)
- Life-threatening or cause permanent damage
- Requires immediate intervention
- Examples: QT prolongation with multiple agents

### üü° Moderate
- May cause deterioration of patient condition
- Requires monitoring or dose adjustment
- Examples: CYP450 enzyme interactions

### üü¢ Minor
- Limited clinical effects
- May not require intervention
- Examples: Minor absorption delays

## Clinical Significance

### High Clinical Significance
- Well-documented in literature
- Consistent effect across patient populations
- Clear mechanism of action

### Moderate Clinical Significance
- Some documentation available
- Variable effects depending on patient factors
- Theoretical basis with limited clinical data

### Low Clinical Significance
- Limited or anecdotal evidence
- Rare occurrence
- Theoretical concern only

## Oncology-Specific Considerations

### Chemotherapy Interactions
- Narrow therapeutic windows
- Combination therapy protocols
- Sequential vs. concurrent administration

### Supportive Care Interactions
- Antiemetics and QT prolongation
- Growth factor interactions
- Infection prophylaxis considerations

### Targeted Therapy Interactions
- CYP450 enzyme effects
- Transporter protein interactions
- Protein binding displacement

## Using the Interaction Checker

1. **Add Medications**: Enter all current medications
2. **Review Results**: Check severity and recommendations
3. **Clinical Assessment**: Consider patient-specific factors
4. **Monitor**: Follow recommended monitoring parameters
5. **Document**: Record decisions and rationale

## Best Practices

- Always check interactions before prescribing
- Consider pharmacokinetic and pharmacodynamic factors
- Review patient-specific risk factors
- Monitor for signs of interactions
- Educate patients about potential interactions
- Document interaction checks and decisions
        `},{id:"checking-interactions",title:"How to Check Drug Interactions",category:"drug-interactions",tags:["how-to","checker","workflow"],difficulty:"beginner",estimatedReadTime:6,lastUpdated:"2025-01-15",content:`
# How to Check Drug Interactions

Follow this step-by-step guide to effectively use the OncoSafeRx Interaction Checker.

## Step 1: Access the Interaction Checker

1. Navigate to **Interaction Checker** from the main menu
2. You'll see an interface to add medications

## Step 2: Add Medications

### Adding Your First Drug
1. Start typing in the medication search field
2. Select from the autocomplete suggestions
3. The drug will appear in your medication list

### Adding Additional Drugs
1. Repeat the search process for each medication
2. You need at least 2 drugs to check interactions
3. You can add up to 10 medications at once

### Enhanced Search Features
- **Case-insensitive**: Works with any capitalization
- **Partial matching**: "pembro" finds "pembrolizumab"
- **Brand and generic names**: Both are searchable
- **Recent searches**: Quick access to previously searched drugs

## Step 3: Review Your Medication List

Before checking interactions:
- Verify all medications are correct
- Remove any incorrect entries using the X button
- Ensure dosage forms are appropriate

## Step 4: Run the Interaction Check

1. Click **Check Interactions** button
2. The system will analyze all possible drug pairs
3. Results appear with severity ratings and details

## Step 5: Interpret Results

### No Interactions Found
- Green checkmark indicates no known interactions
- Safe to proceed with current combination

### Interactions Detected
Results show:
- **Severity level** (Major/Moderate/Minor)
- **Interaction description**
- **Clinical recommendations**
- **Monitoring requirements**

### Interaction Details Include:
- Mechanism of interaction
- Expected onset time
- Clinical significance
- Management strategies
- Literature references

## Step 6: Clinical Decision Making

### For Major Interactions:
- Consider alternative medications
- If unavoidable, implement intensive monitoring
- Adjust dosages as recommended
- Document rationale for continuing

### For Moderate Interactions:
- Assess benefit vs. risk
- Implement monitoring plans
- Consider dose adjustments
- Patient education about signs to watch

### For Minor Interactions:
- Generally safe to continue
- Minimal monitoring may be needed
- Consider timing of administration

## Advanced Features

### Patient Context
- Add patient-specific information
- Consider comorbidities
- Account for age and organ function

### Export Results
- Print interaction reports
- Save for medical records
- Share with healthcare team

## Example Workflow

Let's check interactions for a patient on:
1. Pembrolizumab (immunotherapy)
2. Warfarin (anticoagulation)
3. Ondansetron (antiemetic)

1. Add "pembrolizumab" ‚Üí Select from suggestions
2. Add "warfarin" ‚Üí Select from suggestions  
3. Add "ondansetron" ‚Üí Select from suggestions
4. Click "Check Interactions"
5. Review results for each drug pair
6. Implement monitoring based on recommendations

## Troubleshooting

### Drug Not Found?
- Try alternative names (brand vs. generic)
- Check spelling
- Use partial names
- Contact support if still not found

### Unexpected Results?
- Verify correct drug was selected
- Check for similar drug names
- Review interaction mechanisms
- Consult additional references if needed
        `}]},{id:"pharmacogenomics",name:"Pharmacogenomics",description:"Genetic factors affecting drug response",icon:"Dna",articles:[{id:"pgx-introduction",title:"Introduction to Pharmacogenomics",category:"pharmacogenomics",tags:["genetics","personalized medicine","dosing"],difficulty:"intermediate",estimatedReadTime:10,lastUpdated:"2025-01-15",content:`
# Introduction to Pharmacogenomics

Pharmacogenomics (PGx) is the study of how genetic variations affect individual responses to medications.

## What is Pharmacogenomics?

Pharmacogenomics combines pharmacology and genomics to develop safe and effective medications tailored to an individual's genetic makeup.

### Key Concepts

**Genetic Polymorphisms**: Variations in genes that affect drug metabolism, transport, or targets

**Phenotypes**: Observable characteristics resulting from genetic variations:
- **Poor Metabolizer (PM)**: Reduced enzyme activity
- **Intermediate Metabolizer (IM)**: Somewhat reduced activity
- **Normal Metabolizer (NM)**: Normal enzyme activity
- **Rapid Metabolizer (RM)**: Increased enzyme activity
- **Ultra-rapid Metabolizer (UM)**: Very high enzyme activity

## Important Pharmacogenes in Oncology

### CYP2D6
- **Drugs affected**: Tamoxifen, codeine, tramadol
- **Clinical impact**: Tamoxifen efficacy depends on CYP2D6 activity
- **Recommendations**: Consider alternative therapy for poor metabolizers

### CYP2C19
- **Drugs affected**: Proton pump inhibitors, clopidogrel
- **Clinical impact**: Varies efficacy of acid suppression and antiplatelet therapy
- **Recommendations**: Dose adjustments or alternative medications

### TPMT (Thiopurine S-methyltransferase)
- **Drugs affected**: 6-mercaptopurine, azathioprine, thioguanine
- **Clinical impact**: Risk of severe myelosuppression
- **Recommendations**: Dose reduction or alternative therapy for poor metabolizers

### DPYD (Dihydropyrimidine dehydrogenase)
- **Drugs affected**: 5-fluorouracil, capecitabine
- **Clinical impact**: Risk of severe toxicity
- **Recommendations**: Dose reduction or avoid in deficient patients

### UGT1A1
- **Drugs affected**: Irinotecan
- **Clinical impact**: Risk of severe diarrhea and neutropenia
- **Recommendations**: Dose reduction for specific genotypes

## CPIC Guidelines

The Clinical Pharmacogenetics Implementation Consortium (CPIC) provides evidence-based guidelines for implementing pharmacogenetic testing.

### CPIC Recommendation Levels
- **Level A**: Strong recommendation for genetic testing
- **Level B**: Moderate recommendation
- **Level C**: Optional recommendation
- **Level D**: No recommendation

## Using PGx Information in OncoSafeRx

### 1. Enter Patient Genetic Information
- Input known genetic test results
- Use standardized nomenclature
- Include relevant phenotype predictions

### 2. Review Drug-Specific Recommendations
- CPIC guideline summaries
- Dosing recommendations
- Alternative medication suggestions

### 3. Clinical Decision Support
- Automated alerts for high-risk combinations
- Dosing calculators
- Monitoring recommendations

## Clinical Implementation

### When to Consider PGx Testing
- Before starting medications with strong PGx evidence
- After adverse drug reactions
- For patients with family history of drug reactions
- In precision medicine protocols

### Interpreting Results
- Understand the specific gene-drug pairs
- Consider phenotype predictions
- Account for other clinical factors
- Document decisions and rationale

### Patient Education
- Explain the role of genetics in drug response
- Discuss implications for current and future medications
- Provide genetic test results summary
- Encourage sharing with other healthcare providers

## Limitations and Considerations

### Test Limitations
- Not all relevant genes may be tested
- Rare variants may not be detected
- Phenotype prediction may not always correlate with clinical response

### Clinical Factors
- Drug interactions can affect PGx predictions
- Disease state may influence drug metabolism
- Age and organ function remain important
- Environmental factors can modify genetic effects

## Future Directions

- Expanded gene panels
- Improved phenotype prediction algorithms
- Integration with electronic health records
- Cost-effectiveness studies
- Population-specific research

Pharmacogenomics represents a key component of personalized medicine in oncology, helping optimize drug selection and dosing for individual patients.
        `}]},{id:"safety-monitoring",name:"Safety & Monitoring",description:"Drug safety and monitoring protocols",icon:"Shield",articles:[{id:"safety-basics",title:"Drug Safety Fundamentals",category:"safety-monitoring",tags:["safety","monitoring","adverse events"],difficulty:"intermediate",estimatedReadTime:7,lastUpdated:"2025-01-15",content:`
# Drug Safety Fundamentals

Drug safety is paramount in oncology care, where patients often receive multiple medications with narrow therapeutic windows.

## Key Safety Concepts

### Adverse Drug Reactions (ADRs)
**Type A (Augmented)**: Dose-dependent, predictable
- Examples: Myelosuppression from chemotherapy
- Management: Dose reduction, supportive care

**Type B (Bizarre)**: Dose-independent, unpredictable
- Examples: Anaphylaxis, idiosyncratic reactions
- Management: Discontinuation, symptomatic treatment

### Risk Assessment
- Patient-specific factors
- Drug-specific toxicities
- Interaction potential
- Monitoring capabilities

## Safety Monitoring Protocols

### Pre-treatment Assessment
- Baseline laboratory values
- Organ function tests
- Performance status
- Comorbidity evaluation
- Medication reconciliation

### During Treatment
- Regular laboratory monitoring
- Clinical assessments
- Patient-reported outcomes
- Dose modifications as needed

### Post-treatment
- Long-term toxicity surveillance
- Secondary malignancy screening
- Quality of life assessments

## Common Oncology Toxicities

### Hematologic
- **Myelosuppression**: Regular CBC monitoring
- **Thrombocytopenia**: Bleeding precautions
- **Neutropenia**: Infection prevention

### Gastrointestinal
- **Nausea/Vomiting**: Prophylactic antiemetics
- **Diarrhea**: Electrolyte monitoring
- **Mucositis**: Oral care protocols

### Cardiovascular
- **Cardiotoxicity**: ECHO/MUGA monitoring
- **QT Prolongation**: ECG surveillance
- **Hypertension**: Blood pressure monitoring

### Renal/Hepatic
- **Nephrotoxicity**: Creatinine, BUN monitoring
- **Hepatotoxicity**: Liver function tests

## Monitoring Technologies

### Laboratory Integration
- Automated alerts for critical values
- Trending of serial measurements
- Reference range adjustments

### Clinical Decision Support
- Drug-specific monitoring protocols
- Dose adjustment algorithms
- Toxicity grading systems

## Documentation and Reporting

### Adverse Event Documentation
- Severity grading (CTCAE)
- Causality assessment
- Timeline of events
- Management actions taken

### Regulatory Reporting
- Serious adverse events
- Unexpected reactions
- FDA MedWatch reporting
- Institutional reporting

Effective safety monitoring requires systematic approaches, appropriate technology, and clear communication among healthcare team members.
        `}]},{id:"troubleshooting",name:"Troubleshooting",description:"Common issues and solutions",icon:"Tool",articles:[{id:"common-issues",title:"Common Issues and Solutions",category:"troubleshooting",tags:["troubleshooting","errors","support"],difficulty:"beginner",estimatedReadTime:5,lastUpdated:"2025-01-15",content:`
# Common Issues and Solutions

Quick solutions to frequently encountered problems in OncoSafeRx.

## Search Issues

### Problem: "Drug not found in search"
**Solutions:**
- Try alternative drug names (brand vs. generic)
- Check spelling
- Use partial names (e.g., "pembro" for pembrolizumab)
- Try different capitalizations
- Contact support if drug should be available

### Problem: "Search suggestions not appearing"
**Solutions:**
- Type at least 2 characters
- Check internet connection
- Clear browser cache
- Try refreshing the page
- Disable browser extensions temporarily

### Problem: "Search is too slow"
**Solutions:**
- Check internet connection speed
- Clear browser cache and cookies
- Close unnecessary browser tabs
- Try incognito/private browsing mode

## Interaction Checker Issues

### Problem: "Cannot add second drug"
**Solutions:**
- Ensure first drug is properly selected
- Wait for first drug to appear in list
- Try refreshing the page
- Clear the form and start over

### Problem: "Interaction check not working"
**Solutions:**
- Ensure at least 2 drugs are selected
- Verify drugs are correctly added to list
- Check for server connectivity
- Try with different drug combinations

### Problem: "Unexpected interaction results"
**Solutions:**
- Verify correct drugs were selected
- Check for similar drug names
- Review interaction mechanisms
- Consult additional references

## Performance Issues

### Problem: "Page loading slowly"
**Solutions:**
- Check internet connection
- Clear browser cache
- Disable unnecessary browser extensions
- Try different browser
- Check system resources

### Problem: "Application freezing"
**Solutions:**
- Close and reopen browser tab
- Restart browser
- Clear browser data
- Check for browser updates
- Try incognito mode

## Data Issues

### Problem: "Information seems outdated"
**Solutions:**
- Refresh the page
- Check last updated timestamps
- Clear browser cache
- Report outdated information to support

### Problem: "Missing drug information"
**Solutions:**
- Try alternative drug identifiers
- Check if drug is recently approved
- Contact support to request addition
- Use alternative data sources temporarily

## Browser Compatibility

### Recommended Browsers
- **Chrome**: Version 90 or later
- **Firefox**: Version 88 or later
- **Safari**: Version 14 or later
- **Edge**: Version 90 or later

### Browser Settings
- Enable JavaScript
- Allow cookies
- Disable strict tracking protection
- Clear cache regularly

## Getting Additional Help

### In-App Support
- Use the AI chat assistant
- Check tooltips and help text
- Browse knowledge base articles

### Contact Support
- Email: support@oncosaferx.com
- Include error messages
- Describe steps to reproduce
- Mention browser and version

### Community Resources
- User forums
- Video tutorials
- Training materials
- Best practices guides

Remember: Most issues can be resolved by refreshing the page or clearing browser cache. If problems persist, don't hesitate to contact our support team.
        `}]}],B=r=>{if(!r||r.length<2)return[];const n=r.toLowerCase();return C.flatMap(c=>c.articles).filter(c=>c.title.toLowerCase().includes(n)||c.content.toLowerCase().includes(n)||c.tags.some(u=>u.toLowerCase().includes(n))||c.category.toLowerCase().includes(n)).sort((c,u)=>{const m=c.title.toLowerCase().includes(n),l=u.title.toLowerCase().includes(n);return m&&!l?-1:!m&&l?1:0})},z={PlayCircle:X,AlertTriangle:H,Dna:G,Shield:F,Tool:Q},ne=({className:r=""})=>{const[n,f]=d.useState(""),c=d.useMemo(()=>C.flatMap(s=>s.articles.map(x=>({value:x.id,label:x.title,description:`${s.name} ‚Ä¢ ${x.tags.join(", ")}`,category:s.name,metadata:x}))),[]),[u,m]=d.useState(null),[l,p]=d.useState(null),y=d.useMemo(()=>n.length<2?[]:B(n),[n]),a=t=>{m(t),p(null),f("")},v=t=>{p(t)},b=()=>{l?p(null):u&&m(null)},w=t=>{switch(t){case"beginner":return"bg-green-100 text-green-800";case"intermediate":return"bg-yellow-100 text-yellow-800";case"advanced":return"bg-red-100 text-red-800";default:return"bg-gray-100 text-gray-800"}},S=t=>t.replace(/^# (.*$)/gm,'<h1 class="text-2xl font-bold text-gray-900 mt-6 mb-4">$1</h1>').replace(/^## (.*$)/gm,'<h2 class="text-xl font-semibold text-gray-900 mt-5 mb-3">$1</h2>').replace(/^### (.*$)/gm,'<h3 class="text-lg font-medium text-gray-900 mt-4 mb-2">$1</h3>').replace(/\*\*(.*?)\*\*/g,'<strong class="font-semibold">$1</strong>').replace(/\*(.*?)\*/g,'<em class="italic">$1</em>').replace(/`(.*?)`/g,'<code class="bg-gray-100 px-1 py-0.5 rounded text-sm font-mono">$1</code>').replace(/^- (.*$)/gm,'<li class="ml-4">‚Ä¢ $1</li>').replace(/^(\d+)\. (.*$)/gm,'<li class="ml-4">$1. $2</li>').replace(/\n\n/g,'</p><p class="mb-4">').replace(/\n/g,"<br/>");if(l)return e.jsxs("div",{className:`max-w-4xl mx-auto ${r}`,children:[e.jsxs("div",{className:"mb-6",children:[e.jsxs("button",{onClick:b,className:"flex items-center space-x-2 text-blue-600 hover:text-blue-700 font-medium mb-4",children:[e.jsx(U,{className:"w-4 h-4"}),e.jsx("span",{children:"Back to Knowledge Base"})]}),e.jsxs("div",{className:"mb-4",children:[e.jsx("h1",{className:"text-3xl font-bold text-gray-900 mb-2",children:l.title}),e.jsxs("div",{className:"flex items-center space-x-4 text-sm text-gray-600",children:[e.jsxs("div",{className:"flex items-center space-x-1",children:[e.jsx(k,{className:"w-4 h-4"}),e.jsxs("span",{children:[l.estimatedReadTime," min read"]})]}),e.jsx("span",{className:`px-2 py-1 rounded-full text-xs font-medium ${w(l.difficulty)}`,children:l.difficulty}),e.jsxs("span",{children:["Updated ",l.lastUpdated]})]}),e.jsx("div",{className:"flex items-center space-x-2 mt-2",children:l.tags.map(t=>e.jsxs("span",{className:"inline-flex items-center px-2 py-1 rounded-full text-xs bg-blue-100 text-blue-800",children:[e.jsx(I,{className:"w-3 h-3 mr-1"}),t]},t))})]})]}),e.jsx(h,{className:"prose max-w-none",children:e.jsx("div",{className:"text-gray-700 leading-relaxed",dangerouslySetInnerHTML:{__html:`<p class="mb-4">${S(l.content)}</p>`}})})]});if(u){const t=C.find(s=>s.id===u);return t?e.jsxs("div",{className:`max-w-4xl mx-auto ${r}`,children:[e.jsxs("div",{className:"mb-6",children:[e.jsxs("button",{onClick:b,className:"flex items-center space-x-2 text-blue-600 hover:text-blue-700 font-medium mb-4",children:[e.jsx(U,{className:"w-4 h-4"}),e.jsx("span",{children:"Back to Categories"})]}),e.jsxs("div",{className:"flex items-center space-x-3 mb-2",children:[L.createElement(z[t.icon]||j,{className:"w-8 h-8 text-blue-600"}),e.jsx("h1",{className:"text-3xl font-bold text-gray-900",children:t.name})]}),e.jsx("p",{className:"text-lg text-gray-600",children:t.description})]}),e.jsx("div",{className:"space-y-4",children:t.articles.map(s=>e.jsx(h,{className:"cursor-pointer hover:shadow-md transition-shadow",onClick:()=>v(s),children:e.jsxs("div",{className:"flex items-start justify-between",children:[e.jsxs("div",{className:"flex-1",children:[e.jsx("h3",{className:"text-lg font-semibold text-gray-900 mb-2",children:s.title}),e.jsxs("div",{className:"flex items-center space-x-4 text-sm text-gray-600 mb-3",children:[e.jsxs("div",{className:"flex items-center space-x-1",children:[e.jsx(k,{className:"w-4 h-4"}),e.jsxs("span",{children:[s.estimatedReadTime," min read"]})]}),e.jsx("span",{className:`px-2 py-1 rounded-full text-xs font-medium ${w(s.difficulty)}`,children:s.difficulty})]}),e.jsx("div",{className:"flex items-center space-x-2",children:s.tags.map(x=>e.jsxs("span",{className:"inline-flex items-center px-2 py-1 rounded-full text-xs bg-gray-100 text-gray-700",children:[e.jsx(I,{className:"w-3 h-3 mr-1"}),x]},x))})]}),e.jsx(A,{className:"w-5 h-5 text-gray-400 flex-shrink-0 ml-4"})]})},s.id))})]}):null}return e.jsxs("div",{className:`max-w-4xl mx-auto ${r}`,children:[e.jsxs("div",{className:"mb-8",children:[e.jsx("h1",{className:"text-3xl font-bold text-gray-900 mb-2",children:"Knowledge Base"}),e.jsx("p",{className:"text-lg text-gray-600",children:"Comprehensive guides and documentation for OncoSafeRx"})]}),e.jsx("div",{className:"mb-8",children:e.jsx(K,{options:c,value:n,placeholder:"Search the knowledge base...",onSelect:t=>{f(t.label),p(t.metadata)},onChange:f,highlightMatches:!0,groupByCategory:!0,maxResults:12,minChars:1})}),n.length>=2&&e.jsxs("div",{className:"mb-8",children:[e.jsxs("h2",{className:"text-xl font-semibold text-gray-900 mb-4",children:["Search Results (",y.length,")"]}),y.length>0?e.jsx("div",{className:"space-y-4",children:y.map(t=>e.jsx(h,{className:"cursor-pointer hover:shadow-md transition-shadow",onClick:()=>v(t),children:e.jsxs("div",{className:"flex items-start justify-between",children:[e.jsxs("div",{className:"flex-1",children:[e.jsx("h3",{className:"text-lg font-semibold text-gray-900 mb-2",children:t.title}),e.jsxs("div",{className:"flex items-center space-x-4 text-sm text-gray-600 mb-3",children:[e.jsxs("div",{className:"flex items-center space-x-1",children:[e.jsx(k,{className:"w-4 h-4"}),e.jsxs("span",{children:[t.estimatedReadTime," min read"]})]}),e.jsx("span",{className:`px-2 py-1 rounded-full text-xs font-medium ${w(t.difficulty)}`,children:t.difficulty}),e.jsx("span",{children:C.find(s=>s.id===t.category)?.name})]}),e.jsx("div",{className:"flex items-center space-x-2",children:t.tags.map(s=>e.jsxs("span",{className:"inline-flex items-center px-2 py-1 rounded-full text-xs bg-gray-100 text-gray-700",children:[e.jsx(I,{className:"w-3 h-3 mr-1"}),s]},s))})]}),e.jsx(A,{className:"w-5 h-5 text-gray-400 flex-shrink-0 ml-4"})]})},t.id))}):e.jsxs(h,{className:"text-center text-gray-500 py-8",children:[e.jsx(j,{className:"w-12 h-12 mx-auto mb-4 text-gray-300"}),e.jsxs("p",{children:['No articles found matching "',n,'"']}),e.jsx("p",{className:"text-sm mt-2",children:"Try different keywords or browse by category below"})]})]}),n.length<2&&e.jsxs("div",{children:[e.jsx("h2",{className:"text-xl font-semibold text-gray-900 mb-6",children:"Browse by Category"}),e.jsx("div",{className:"grid md:grid-cols-2 lg:grid-cols-3 gap-6",children:C.map(t=>{const s=z[t.icon]||j;return e.jsxs(h,{className:"cursor-pointer hover:shadow-md transition-shadow text-center p-6",onClick:()=>a(t.id),children:[e.jsx(s,{className:"w-12 h-12 mx-auto mb-4 text-blue-600"}),e.jsx("h3",{className:"text-lg font-semibold text-gray-900 mb-2",children:t.name}),e.jsx("p",{className:"text-gray-600 text-sm mb-4",children:t.description}),e.jsxs("div",{className:"text-sm text-blue-600 font-medium",children:[t.articles.length," article",t.articles.length!==1?"s":""]})]},t.id)})})]})]})},ae=({isOpen:r,onClose:n,className:f=""})=>{const[c,u]=d.useState([{id:"1",type:"ai",content:"Hello! I'm your OncoSafeRx assistant. I can help you with drug interactions, pharmacogenomics, safety monitoring, and navigating the platform. What can I help you with today?",timestamp:new Date}]),[m,l]=d.useState(""),[p,y]=d.useState(!1),[a,v]=d.useState(!1),b=d.useRef(null),w=d.useRef(null),S=()=>{b.current?.scrollIntoView({behavior:"smooth"})};d.useEffect(()=>{S()},[c]),d.useEffect(()=>{r&&!a&&w.current?.focus()},[r,a]);const t=o=>{const i=o.toLowerCase(),g=B(o).slice(0,3).map(N=>N.id);return i.includes("drug interaction")||i.includes("interaction check")?{content:`To check drug interactions in OncoSafeRx:

1. Go to the **Interaction Checker** from the main menu
2. Start typing medication names in the search field
3. Select drugs from the autocomplete suggestions
4. Add at least 2 medications to your list
5. Click **Check Interactions** to see results

The system will show:
- Severity levels (Major/Moderate/Minor)
- Clinical recommendations
- Monitoring requirements
- Management strategies

Would you like me to explain any specific aspect of drug interactions?`,relatedArticles:g}:i.includes("search")||i.includes("find drug")||i.includes("medication")?{content:`To search for medications:

1. Use the **Drug Search** feature from the main menu
2. Type at least 2 characters of the drug name
3. Select from autocomplete suggestions
4. View detailed drug information

**Search Tips:**
- Use generic or brand names
- Case doesn't matter ("ASPIRIN" = "aspirin")
- Partial names work ("pembro" finds "pembrolizumab")
- Recent searches are saved for quick access

What specific medication are you looking for?`,relatedArticles:g}:i.includes("pharmacogenomic")||i.includes("genetic")||i.includes("pgx")?{content:`Pharmacogenomics in OncoSafeRx helps personalize medication therapy based on genetic factors:

**Key Features:**
- CPIC guideline recommendations
- Dosing adjustments for genetic variants
- Risk assessments for adverse reactions
- Gene-drug interaction alerts

**Important Pharmacogenes:**
- **CYP2D6**: Affects tamoxifen, codeine
- **TPMT**: Critical for thiopurines
- **DPYD**: Essential for 5-FU/capecitabine
- **UGT1A1**: Important for irinotecan

Would you like to know more about a specific gene or drug?`,relatedArticles:g}:i.includes("safety")||i.includes("monitor")||i.includes("toxicity")?{content:`OncoSafeRx provides comprehensive safety monitoring tools:

**Safety Features:**
- Real-time toxicity alerts
- Monitoring protocol recommendations
- Dose adjustment guidelines
- Adverse event tracking

**Common Monitoring Parameters:**
- Hematologic: CBC, platelets
- Cardiac: ECHO, ECG for QT interval
- Hepatic: Liver function tests
- Renal: Creatinine, BUN

**Safety Classifications:**
- üî¥ **Major**: Life-threatening, requires immediate action
- üü° **Moderate**: Requires monitoring/dose adjustment
- üü¢ **Minor**: Limited clinical impact

What specific safety concern can I help you with?`,relatedArticles:g}:i.includes("help")||i.includes("how to")||i.includes("tutorial")?{content:`I'm here to help! Here are some things I can assist you with:

**Getting Started:**
- Navigating the OncoSafeRx interface
- Your first drug search
- Understanding the features

**Drug Interactions:**
- How to check interactions
- Understanding severity levels
- Clinical recommendations

**Pharmacogenomics:**
- Genetic testing interpretation
- Dosing adjustments
- CPIC guidelines

**Safety Monitoring:**
- Toxicity management
- Monitoring protocols
- Adverse event reporting

**Troubleshooting:**
- Common issues and solutions
- Browser compatibility
- Performance optimization

Just ask me about any specific topic!`,relatedArticles:g}:i.includes("oncology")||i.includes("cancer")||i.includes("chemotherapy")?{content:`OncoSafeRx specializes in oncology drug safety and interactions:

**Oncology-Specific Features:**
- Comprehensive cancer drug database
- Chemotherapy interaction checking
- Supportive care medication analysis
- Targeted therapy considerations

**Common Oncology Drugs Covered:**
- Immunotherapies (pembrolizumab, nivolumab)
- Targeted therapies (imatinib, erlotinib)
- Traditional chemotherapies (5-FU, cisplatin)
- Supportive care medications

**Special Considerations:**
- Narrow therapeutic windows
- Combination therapy protocols
- Sequential vs. concurrent administration
- Long-term toxicity monitoring

Which aspect of oncology drug management interests you most?`,relatedArticles:g}:i.includes("error")||i.includes("problem")||i.includes("not working")?{content:`I can help troubleshoot common issues:

**Common Solutions:**
1. **Refresh the page** - Solves many temporary issues
2. **Clear browser cache** - Fixes data loading problems
3. **Check internet connection** - Ensures proper functionality
4. **Try incognito/private mode** - Bypasses extension conflicts

**Specific Issues:**
- **Drug not found**: Try alternative names or spelling
- **Search slow**: Check connection, clear cache
- **Interactions not loading**: Ensure 2+ drugs selected
- **Page freezing**: Restart browser, check resources

**Browser Requirements:**
- Chrome 90+, Firefox 88+, Safari 14+, Edge 90+
- JavaScript enabled
- Cookies allowed

What specific error are you experiencing?`,relatedArticles:g}:i.includes("cpic")||i.includes("guideline")?{content:`CPIC (Clinical Pharmacogenetics Implementation Consortium) guidelines provide evidence-based recommendations:

**CPIC Levels:**
- **Level A**: Strong recommendation for genetic testing
- **Level B**: Moderate recommendation  
- **Level C**: Optional recommendation
- **Level D**: No recommendation

**Key CPIC Guidelines in Oncology:**
- **TPMT/NUDT15** and thiopurines
- **DPYD** and fluoropyrimidines
- **UGT1A1** and irinotecan
- **CYP2D6** and tamoxifen

**Implementation:**
- Review patient genotype
- Apply dosing recommendations
- Monitor for expected effects
- Document clinical decisions

Which specific CPIC guideline would you like to learn about?`,relatedArticles:g}:{content:`I'd be happy to help! I can assist you with:

‚Ä¢ **Drug Interactions** - How to check and interpret results
‚Ä¢ **Drug Search** - Finding medications and their details  
‚Ä¢ **Pharmacogenomics** - Genetic factors affecting drug response
‚Ä¢ **Safety Monitoring** - Toxicity management and protocols
‚Ä¢ **Navigation** - Using OncoSafeRx features effectively
‚Ä¢ **Troubleshooting** - Solving common technical issues

Could you be more specific about what you'd like help with? You can ask questions like:
- "How do I check drug interactions?"
- "What does this interaction mean?"
- "How do I search for a medication?"
- "What is pharmacogenomics?"`,relatedArticles:g}},s=async()=>{if(!m.trim())return;const o={id:Date.now().toString(),type:"user",content:m,timestamp:new Date};u(i=>[...i,o]),l(""),y(!0),setTimeout(()=>{const i=t(m),g={id:(Date.now()+1).toString(),type:"ai",content:i.content,timestamp:new Date,relatedArticles:i.relatedArticles};u(N=>[...N,g]),y(!1)},1e3+Math.random()*1e3)},x=o=>{o.key==="Enter"&&!o.shiftKey&&(o.preventDefault(),s())};return r?e.jsxs("div",{className:`fixed bottom-4 right-4 bg-white border border-gray-200 rounded-lg shadow-xl z-50 ${f}`,children:[e.jsxs("div",{className:"flex items-center justify-between p-4 border-b border-gray-200 bg-blue-50 rounded-t-lg",children:[e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(T,{className:"w-5 h-5 text-blue-600"}),e.jsx("h3",{className:"font-semibold text-gray-900",children:"OncoSafeRx Assistant"})]}),e.jsxs("div",{className:"flex items-center space-x-1",children:[e.jsx("button",{onClick:()=>v(!a),className:"p-1 text-gray-400 hover:text-gray-600 focus:outline-none",title:a?"Maximize":"Minimize",children:a?e.jsx(J,{className:"w-4 h-4"}):e.jsx(se,{className:"w-4 h-4"})}),e.jsx("button",{onClick:n,className:"p-1 text-gray-400 hover:text-gray-600 focus:outline-none",title:"Close",children:e.jsx($,{className:"w-4 h-4"})})]})]}),!a&&e.jsxs(e.Fragment,{children:[e.jsxs("div",{className:"h-96 overflow-y-auto p-4 space-y-4",children:[c.map(o=>e.jsx("div",{className:`flex ${o.type==="user"?"justify-end":"justify-start"}`,children:e.jsxs("div",{className:`flex space-x-2 max-w-xs lg:max-w-md ${o.type==="user"?"flex-row-reverse space-x-reverse":"flex-row"}`,children:[e.jsx("div",{className:`flex-shrink-0 w-8 h-8 rounded-full flex items-center justify-center ${o.type==="user"?"bg-blue-600":"bg-gray-100"}`,children:o.type==="user"?e.jsx(Z,{className:"w-4 h-4 text-white"}):e.jsx(T,{className:"w-4 h-4 text-gray-600"})}),e.jsxs("div",{className:`px-3 py-2 rounded-lg ${o.type==="user"?"bg-blue-600 text-white":"bg-gray-100 text-gray-900"}`,children:[e.jsx("div",{className:"text-sm whitespace-pre-wrap",children:o.content}),e.jsx("div",{className:"text-xs mt-1 opacity-70",children:o.timestamp.toLocaleTimeString([],{hour:"2-digit",minute:"2-digit"})})]})]})},o.id)),p&&e.jsx("div",{className:"flex justify-start",children:e.jsxs("div",{className:"flex space-x-2 max-w-xs lg:max-w-md",children:[e.jsx("div",{className:"flex-shrink-0 w-8 h-8 rounded-full bg-gray-100 flex items-center justify-center",children:e.jsx(T,{className:"w-4 h-4 text-gray-600"})}),e.jsx("div",{className:"px-3 py-2 rounded-lg bg-gray-100 text-gray-900",children:e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(q,{className:"w-4 h-4 animate-spin"}),e.jsx("span",{className:"text-sm",children:"Thinking..."})]})})]})}),e.jsx("div",{ref:b})]}),e.jsxs("div",{className:"p-4 border-t border-gray-200",children:[e.jsxs("div",{className:"flex space-x-2",children:[e.jsx("input",{ref:w,type:"text",value:m,onChange:o=>l(o.target.value),onKeyPress:x,placeholder:"Ask me anything about OncoSafeRx...",disabled:p,className:"flex-1 px-3 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500 text-sm disabled:bg-gray-100"}),e.jsx("button",{onClick:s,disabled:!m.trim()||p,className:"px-3 py-2 bg-blue-600 text-white rounded-lg hover:bg-blue-700 focus:outline-none focus:ring-2 focus:ring-blue-500 disabled:opacity-50 disabled:cursor-not-allowed",children:e.jsx(V,{className:"w-4 h-4"})})]}),e.jsx("div",{className:"mt-2 text-xs text-gray-500 text-center",children:"Press Enter to send ‚Ä¢ Shift+Enter for new line"})]})]})]}):null},oe={},je=()=>{const[r,n]=d.useState("overview"),[f,c]=d.useState(!1),u=[{title:"Drug Search",description:"Find medications by name, RXCUI, or active ingredient",icon:W,tips:["Type at least 2 characters to see suggestions","Use generic or brand names","Search is case-insensitive","Recent searches are saved for quick access"]},{title:"Interaction Checker",description:"Check for potential drug interactions",icon:P,tips:["Add at least 2 medications","Review severity ratings carefully","Follow clinical recommendations","Consider patient-specific factors"]},{title:"Pharmacogenomics",description:"Understand genetic factors affecting drug response",icon:_,tips:["Enter known genetic test results","Review CPIC guidelines","Consider dosing adjustments","Document genetic factors"]}],m=oe?.VITE_COMMUNITY_URL||"https://github.com/gdogra/OncoSafeRx/discussions",l=[{title:"AI Assistant",description:"Get instant help with OncoSafeRx features and clinical questions",icon:R,action:()=>c(!0),actionText:"Start Chat"},{title:"Knowledge Base",description:"Browse comprehensive guides and documentation",icon:j,action:()=>n("knowledge-base"),actionText:"Browse Articles"},{title:"Email Support",description:"Contact our support team for technical assistance",icon:D,action:()=>window.open("mailto:support@oncosaferx.com"),actionText:"Send Email"},{title:"Community Forum",description:"Connect with other users and share best practices",icon:Y,action:()=>window.open(m,"_blank","noopener,noreferrer"),actionText:"Visit Forum"},{title:"Auth Diagnostics",description:"Check your session, server verification, and profile status",icon:E,action:()=>window.location.assign("/auth-diagnostics"),actionText:"Open Diagnostics"}],p=()=>e.jsxs("div",{className:"space-y-8",children:[e.jsxs("div",{className:"text-center",children:[e.jsx(P,{className:"w-16 h-16 mx-auto mb-4 text-blue-600"}),e.jsx("h1",{className:"text-3xl font-bold text-gray-900 mb-4",children:"How can we help you?"}),e.jsx("p",{className:"text-lg text-gray-600 max-w-2xl mx-auto",children:"Welcome to the OncoSafeRx Help Center. Find answers to your questions, browse our knowledge base, or chat with our AI assistant for instant help."})]}),e.jsx("div",{className:"grid md:grid-cols-2 lg:grid-cols-4 gap-6",children:l.map(a=>e.jsxs(h,{className:"text-center p-6 cursor-pointer hover:shadow-lg transition-shadow",onClick:a.action,children:[e.jsx(a.icon,{className:"w-10 h-10 mx-auto mb-3 text-blue-600"}),e.jsx("h3",{className:"font-semibold text-gray-900 mb-2",children:a.title}),e.jsx("p",{className:"text-sm text-gray-600 mb-4",children:a.description}),e.jsxs("button",{className:"text-blue-600 hover:text-blue-700 font-medium text-sm",children:[a.actionText," ‚Üí"]})]},a.title))}),e.jsxs("div",{children:[e.jsx("h2",{className:"text-2xl font-bold text-gray-900 mb-6",children:"Quick Help"}),e.jsx("div",{className:"grid md:grid-cols-3 gap-6",children:u.map(a=>e.jsxs(h,{className:"p-6",children:[e.jsx(a.icon,{className:"w-8 h-8 mb-3 text-blue-600"}),e.jsx("h3",{className:"font-semibold text-gray-900 mb-2",children:a.title}),e.jsx("p",{className:"text-gray-600 text-sm mb-4",children:a.description}),e.jsx("ul",{className:"space-y-1",children:a.tips.map((v,b)=>e.jsxs("li",{className:"text-xs text-gray-500 flex items-start",children:[e.jsx("span",{className:"inline-block w-1 h-1 bg-gray-400 rounded-full mt-2 mr-2 flex-shrink-0"}),v]},b))})]},a.title))})]}),e.jsx(O,{type:"info",title:"New to OncoSafeRx?",children:e.jsxs("div",{className:"flex items-center justify-between",children:[e.jsx("p",{children:"Check out our getting started guide to learn the basics and discover key features."}),e.jsx("button",{onClick:()=>n("knowledge-base"),className:"ml-4 px-4 py-2 bg-blue-600 text-white rounded-lg hover:bg-blue-700 font-medium whitespace-nowrap",children:"Get Started"})]})}),e.jsx(h,{className:"bg-gray-50",children:e.jsxs("div",{className:"text-center",children:[e.jsx("h3",{className:"text-lg font-semibold text-gray-900 mb-4",children:"Need More Help?"}),e.jsxs("div",{className:"grid md:grid-cols-2 gap-6",children:[e.jsxs("div",{children:[e.jsx(D,{className:"w-6 h-6 mx-auto mb-2 text-gray-600"}),e.jsx("p",{className:"font-medium text-gray-900",children:"Email Support"}),e.jsx("p",{className:"text-sm text-gray-600",children:"support@oncosaferx.com"}),e.jsx("p",{className:"text-xs text-gray-500 mt-1",children:"Response within 24 hours"})]}),e.jsxs("div",{children:[e.jsx(E,{className:"w-6 h-6 mx-auto mb-2 text-gray-600"}),e.jsx("p",{className:"font-medium text-gray-900",children:"Documentation"}),e.jsx("p",{className:"text-sm text-gray-600",children:"docs.oncosaferx.com"}),e.jsx("p",{className:"text-xs text-gray-500 mt-1",children:"Technical documentation"})]})]})]})})]}),y=()=>e.jsxs("div",{className:"space-y-8",children:[e.jsxs("div",{className:"text-center",children:[e.jsx("h1",{className:"text-3xl font-bold text-gray-900 mb-4",children:"Support & Contact"}),e.jsx("p",{className:"text-lg text-gray-600 max-w-2xl mx-auto",children:"Get help when you need it. Our support team is here to assist you with any questions or issues."})]}),e.jsxs("div",{className:"grid md:grid-cols-2 gap-8",children:[e.jsxs(h,{className:"p-6",children:[e.jsx(R,{className:"w-8 h-8 mb-4 text-blue-600"}),e.jsx("h3",{className:"text-lg font-semibold text-gray-900 mb-3",children:"AI Assistant"}),e.jsx("p",{className:"text-gray-600 mb-4",children:"Get instant answers to your questions about OncoSafeRx features, drug interactions, and clinical guidance."}),e.jsx("button",{onClick:()=>c(!0),className:"w-full px-4 py-2 bg-blue-600 text-white rounded-lg hover:bg-blue-700 font-medium",children:"Start Chat"})]}),e.jsxs(h,{className:"p-6",children:[e.jsx(D,{className:"w-8 h-8 mb-4 text-green-600"}),e.jsx("h3",{className:"text-lg font-semibold text-gray-900 mb-3",children:"Email Support"}),e.jsx("p",{className:"text-gray-600 mb-4",children:"For technical issues, account questions, or detailed inquiries that require human assistance."}),e.jsx("button",{onClick:()=>window.open("mailto:support@oncosaferx.com"),className:"w-full px-4 py-2 bg-green-600 text-white rounded-lg hover:bg-green-700 font-medium",children:"Send Email"})]})]}),e.jsx(O,{type:"info",title:"Before Contacting Support",children:e.jsxs("ul",{className:"list-disc list-inside space-y-1 text-sm",children:[e.jsx("li",{children:"Check our knowledge base for answers to common questions"}),e.jsx("li",{children:"Try the AI assistant for instant help"}),e.jsx("li",{children:"Include specific error messages or screenshots when reporting issues"}),e.jsx("li",{children:"Mention your browser type and version for technical problems"})]})})]});return e.jsxs("div",{className:"min-h-screen bg-gray-50",children:[e.jsxs("div",{className:"max-w-7xl mx-auto px-4 py-8",children:[e.jsxs("div",{className:"flex space-x-1 mb-8 bg-white rounded-lg p-1 shadow-sm",children:[e.jsx("button",{onClick:()=>n("overview"),className:`flex-1 px-4 py-2 text-sm font-medium rounded-md transition-colors ${r==="overview"?"bg-blue-600 text-white":"text-gray-700 hover:text-gray-900 hover:bg-gray-100"}`,children:"Help Overview"}),e.jsx("button",{onClick:()=>n("knowledge-base"),className:`flex-1 px-4 py-2 text-sm font-medium rounded-md transition-colors ${r==="knowledge-base"?"bg-blue-600 text-white":"text-gray-700 hover:text-gray-900 hover:bg-gray-100"}`,children:"Knowledge Base"}),e.jsx("button",{onClick:()=>n("support"),className:`flex-1 px-4 py-2 text-sm font-medium rounded-md transition-colors ${r==="support"?"bg-blue-600 text-white":"text-gray-700 hover:text-gray-900 hover:bg-gray-100"}`,children:"Support & Contact"})]}),r==="overview"&&p(),r==="knowledge-base"&&e.jsx(ne,{}),r==="support"&&y()]}),e.jsx(ae,{isOpen:f,onClose:()=>c(!1)}),!f&&e.jsx("button",{onClick:()=>c(!0),className:"fixed bottom-4 right-4 w-14 h-14 bg-blue-600 text-white rounded-full shadow-lg hover:bg-blue-700 focus:outline-none focus:ring-2 focus:ring-blue-500 focus:ring-offset-2 transition-colors",title:"Chat with AI Assistant",children:e.jsx(R,{className:"w-6 h-6 mx-auto"})})]})};export{je as default};
//# sourceMappingURL=Help-CjgViKmY.js.map
